Literature DB >> 7525410

Single-strand-targeted triplex formation: stability, specificity and RNase H activation properties.

E R Kandimalla1, S Agrawal.   

Abstract

Single-stranded (ss) oligodeoxyribonucleotides (oligos) containing both Watson-Crick and Hoogsteen hydrogen bonding domains joined by either a 5-nucleotide loop or a flexible hexaethylene-glycol linker, called foldback triplex-forming oligos (FTFOs), are designed and studied for their binding affinity and specificity to their ss DNA/RNA targets. Thermal denaturation studies revealed an increased affinity of FTFOs, due to addition of a Hoogsteen hydrogen bonding domain at the binding site, as the Watson-Crick domain forms a double helix with the target, when compared to conventional antisense and antigene oligos. DNase I hydrolysis and electrophoretic mobility shift analysis confirmed the formation of foldback triplexes relative to conventional double- and triple-stranded structures. The FTFOs showed increased sequence specificity mainly arising from their ability to recognize the target sequence twice, first by Watson-Crick base pairing and a second time by Hoogsteen base pairing. An FTFO with DNA components in both duplex- and triplex-forming domains showed preference for a DNA homopurine target strand.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525410     DOI: 10.1016/0378-1119(94)90419-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Preorganization of DNA: Design Principles for Improving Nucleic Acid Recognition by Synthetic Oligonucleotides.

Authors:  Eric T. Kool
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

2.  Formation of Stable DNA Loops by Incorporation of Nonpolar, Non-Hydrogen-Bonding Nucleoside Isosteres.

Authors:  Xiao-Feng Ren; Barbara A Schweitzer; Charles J Sheils; Eric T Kool
Journal:  Angew Chem Int Ed Engl       Date:  1996-04-19       Impact factor: 15.336

3.  Structural Optimization of Non-Nucleotide Loop Replacements for Duplex and Triplex DNAs.

Authors:  Squire Rumney; Eric T Kool
Journal:  J Am Chem Soc       Date:  1995       Impact factor: 15.419

4.  Recognition of DNA, RNA, and Proteins by Circular Oligonucleotides.

Authors:  Eric T Kool
Journal:  Acc Chem Res       Date:  1998-08-18       Impact factor: 22.384

5.  Relative stabilities of triple helices composed of combinations of DNA, RNA and 2'-O-methyl-RNA backbones: chimeric circular oligonucleotides as probes.

Authors:  S Wang; E T Kool
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

6.  Very High Affinity DNA Recognition by Bicyclic and Cross-Linked Oligonucleotides.

Authors:  Narayan C Chaudhuri; Eric T Kool
Journal:  J Am Chem Soc       Date:  1995-10-01       Impact factor: 15.419

7.  Thermodynamic basis for engineering high-affinity, high-specificity binding-induced DNA clamp nanoswitches.

Authors:  Andrea Idili; Kevin W Plaxco; Alexis Vallée-Bélisle; Francesco Ricci
Journal:  ACS Nano       Date:  2013-11-20       Impact factor: 15.881

8.  Single strand targeted triplex formation: targeting purine-pyrimidine mixed sequences using abasic linkers.

Authors:  E R Kandimalla; A N Manning; G Venkataraman; V Sasisekharan; S Agrawal
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

9.  Single strand targeted triplex-formation. Destabilization of guanine quadruplex structures by foldback triplex-forming oligonucleotides.

Authors:  E R Kandimalla; S Agrawal
Journal:  Nucleic Acids Res       Date:  1995-03-25       Impact factor: 16.971

10.  Development of bis-locked nucleic acid (bisLNA) oligonucleotides for efficient invasion of supercoiled duplex DNA.

Authors:  Pedro M D Moreno; Sylvain Geny; Y Vladimir Pabon; Helen Bergquist; Eman M Zaghloul; Cristina S J Rocha; Iulian I Oprea; Burcu Bestas; Samir El Andaloussi; Per T Jørgensen; Erik B Pedersen; Karin E Lundin; Rula Zain; Jesper Wengel; C I Edvard Smith
Journal:  Nucleic Acids Res       Date:  2013-01-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.